Mj. Benvenga et Jd. Leander, INCREASED FOOD-CONSUMPTION BY CLOZAPINE, BUT NOT BY OLANZAPINE, IN SATIATED RATS, Drug development research, 41(1), 1997, pp. 48-50
Various drugs used to treat schizophrenia have been repeatedly shown t
o increase body weight in both animals and humans. There are different
theories as to why this occurs, but the most recently studied theory
is that these drugs which cause weight gain do so because of an antago
nist effect at the 5HT2(c) receptor. In this work, we studied the effe
cts of olanzapine, clozapine, and risperidone on feeding behavior. Ove
r a 4-hour test period in satiated rats, clozapine, over a broad dose
range, significantly increased food consumption. Similarly, risperidon
e increased food consumption relative to control. In contrast, olanzap
ine did not significantly increase food consumption in rats at any dos
e tested over the 4-hour test period. This suggests that olanzapine ma
y be different from clozapine and risperidone with respect to potentia
l weight gain in schizophrenic patients. Moreover, we believe that the
effect produced by clozapine and risperidone is due to the alpha-adre
nergic activity of these compounds, since olanzapine has a much lower
affinity for alpha adrenergic receptors than does clozapine or risperi
done, and not due to the 5HT2(c) activity, which all three compounds h
ave in common. (C) 1997 Wiley-Liss, Inc.